Dynagen, Inc. – Trademark Portfolio
Entity Type: 03
Dynagen, Inc. holds 37 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 32 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include NICCHECK. The owner is based in Cambridge, MA.
99 Erie Street
Cambridge, MA 02139
Showing of trademarks Trademarks
Trademark Classifications
Dynagen, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Dynagen, Inc. have?
Dynagen, Inc. has 37 U.S. trademarks filed with the USPTO. Of these, 1 registered, 26 abandoned, 10 cancelled.
What trademark classes does Dynagen, Inc. file in?
Dynagen, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 11 (Environmental Control), Class 10 (Medical Apparatus), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Dynagen, Inc.'s most well-known trademarks?
Dynagen, Inc.'s registered trademark portfolio includes well-known marks such as NICCHECK. These are among 1 currently registered trademark in the portfolio.
What is Dynagen, Inc.'s trademark registration success rate?
Dynagen, Inc. has a 3% trademark registration rate, with 1 out of 37 resolved applications resulting in successful registration. Currently, 0 applications are pending review.